Home » News and Development » UK. Booming legal medicinal cannabis sales for UK company GW Pharmaceuticals

UK. Booming legal medicinal cannabis sales for UK company GW Pharmaceuticals

UK companyGW Pharmaceuticalsare seeing booming sales of their 'Sativex' oral spray which has led to a 16% rise in revenues.  GW have UK Government approval to grow cannabis on an industrial scale in their UK headquarters which is then converted into an oral spray which contains a balanced formula of 1:1, THC:CBD. 
The initial intention was to sell the 'Sativex' spray for treatment of MS (Multiple Sclerosis), but more recently the firm (and its investors) are increasingly excited by the possibility of using Sativex for relief of advanced cancer pain.  GW Pharma are currently working their way through the third phase of testing in the USA for cancer pain relief with good results.  On top of that they have successfully completed a listing on the NASDAQ stock exchange which has raised important cash for future 'growth'.
Sativex is sold in 21 countries, with more expected to join the list soon.  Many investors are expecting to see significant sales of legal cannabis medicines as continued medical research highlights the growing uses of medical marijuana.
June 4th 2013

Related items

Recent comments (0)

Leave a comment

Your comment
Type the characters you see in the picture below
I would like to receive the newsletter
Contact   |   Disclaimer   |   Privacy policy, terms and conditions

Dutch Passion advise their customers to reassure themselves of local applicable laws and regulations before germination. Dutch Passion cannot be held responsible for the actions of those who act against laws and regulations that apply in their locality. Cannabis seeds should be kept as collectible souvenirs by anyone in an area where cultivation of cannabis is not legal.